High mobility group nucleosomal binding domain 2 pseudogene 22 (HMGN2P22)

High mobility group nucleosomal binding domain 2 pseudogene 22 (HMGN2P22) is a human genomic pseudogene homologous to the HMGN2 gene family, but incapable of encoding a functional protein. Pseudogenes like HMGN2P22 generally arise due to gene duplication or retrotransposition and can sometimes participate in gene regulation through the production of non-coding RNAs or by affecting the stability of functional gene transcripts. However, the specific biological or clinical relevance of HMGN2P22 has not been described in scientific literature and it is not recognized as a therapeutic drug target[5][7][9][12][13]. If searching for a therapeutic target such as a receptor, enzyme, transporter, or protein, HMGN2P22 does not qualify. If interested in gene regulation by non-coding RNAs derived from pseudogenes, broader literature on pseudogene function and mechanism may be relevant[1][3][8][10].

None reported. Drugs do not target HMGN2P22; if any function exists, it would be regulatory at the RNA level, not a typical pharmacological interaction